Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1997-3-14
pubmed:abstractText
1. Activation of metabotropic glutamate receptors (mGluRs) inhibits a transient Ca(2+)-activated K+ current (IAHP) responsible for the slow after-hyperpolarization that follows depolarizations of dentate granule neurones in rat hippocampal brain slices. Here we show for the first time that this physiological consequence of mGluR stimulation is selectively attenuated by blockers of protein tyrosine kinases (PTKs). 2. Several distinct types of PTK blockers, including genistein, tyrphostin-B42 and lavendustin-A, reduced the inhibition of IAHP by the selective mGluR agonist (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid (ACPD). Inhibition of IAHP by 5-HT was unaffected. The PTK blockers by themselves doubled the duration of IAHP suggesting that there exists a tonic inhibitory influence on IAHP that is reduced by PTK antagonists. 3. Inclusion of EGTA (1 mM) in the patch pipette also potentiated the IAHP and reduced the inhibitory action of ACPD on IAHP, consistent with the observation of others that chelation of intracellular Ca2+ prevents protein tyrosine phosphorylation induced by ACPD. 4. we propose that mGluR-initiated inositol 1,4,5-trisphosphate (InsP3) production mobilizes intracellular Ca2+ and leads to increased protein tyrosine phosphorylation which in turn leads to inhibition of IAHP.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8910202-1326293, http://linkedlifedata.com/resource/pubmed/commentcorrection/8910202-1382299, http://linkedlifedata.com/resource/pubmed/commentcorrection/8910202-1383003, http://linkedlifedata.com/resource/pubmed/commentcorrection/8910202-1426765, http://linkedlifedata.com/resource/pubmed/commentcorrection/8910202-1656271, http://linkedlifedata.com/resource/pubmed/commentcorrection/8910202-2172830, http://linkedlifedata.com/resource/pubmed/commentcorrection/8910202-2928346, http://linkedlifedata.com/resource/pubmed/commentcorrection/8910202-7509378, http://linkedlifedata.com/resource/pubmed/commentcorrection/8910202-7513125, http://linkedlifedata.com/resource/pubmed/commentcorrection/8910202-7514272, http://linkedlifedata.com/resource/pubmed/commentcorrection/8910202-7537494, http://linkedlifedata.com/resource/pubmed/commentcorrection/8910202-7544443, http://linkedlifedata.com/resource/pubmed/commentcorrection/8910202-7623957, http://linkedlifedata.com/resource/pubmed/commentcorrection/8910202-7683685, http://linkedlifedata.com/resource/pubmed/commentcorrection/8910202-7852357, http://linkedlifedata.com/resource/pubmed/commentcorrection/8910202-8003312, http://linkedlifedata.com/resource/pubmed/commentcorrection/8910202-8127887, http://linkedlifedata.com/resource/pubmed/commentcorrection/8910202-8152485, http://linkedlifedata.com/resource/pubmed/commentcorrection/8910202-8247151, http://linkedlifedata.com/resource/pubmed/commentcorrection/8910202-8261514, http://linkedlifedata.com/resource/pubmed/commentcorrection/8910202-8386729, http://linkedlifedata.com/resource/pubmed/commentcorrection/8910202-8787834
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/1-amino-1,3-dicarboxycyclopentane, http://linkedlifedata.com/resource/pubmed/chemical/Adenylate Cyclase, http://linkedlifedata.com/resource/pubmed/chemical/Calcium, http://linkedlifedata.com/resource/pubmed/chemical/Cycloleucine, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Genistein, http://linkedlifedata.com/resource/pubmed/chemical/Isoflavones, http://linkedlifedata.com/resource/pubmed/chemical/Neurotoxins, http://linkedlifedata.com/resource/pubmed/chemical/Potassium Channels, http://linkedlifedata.com/resource/pubmed/chemical/Protein-Tyrosine Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Metabotropic Glutamate, http://linkedlifedata.com/resource/pubmed/chemical/Staurosporine
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0022-3751
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
496 ( Pt 1)
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
139-44
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:8910202-Adenylate Cyclase, pubmed-meshheading:8910202-Animals, pubmed-meshheading:8910202-Calcium, pubmed-meshheading:8910202-Cycloleucine, pubmed-meshheading:8910202-Dentate Gyrus, pubmed-meshheading:8910202-Enzyme Activation, pubmed-meshheading:8910202-Enzyme Inhibitors, pubmed-meshheading:8910202-Genistein, pubmed-meshheading:8910202-Isoflavones, pubmed-meshheading:8910202-Male, pubmed-meshheading:8910202-Neuronal Plasticity, pubmed-meshheading:8910202-Neurons, pubmed-meshheading:8910202-Neurotoxins, pubmed-meshheading:8910202-Potassium Channels, pubmed-meshheading:8910202-Protein-Tyrosine Kinases, pubmed-meshheading:8910202-Rats, pubmed-meshheading:8910202-Rats, Wistar, pubmed-meshheading:8910202-Receptors, Metabotropic Glutamate, pubmed-meshheading:8910202-Staurosporine
pubmed:year
1996
pubmed:articleTitle
Tyrosine kinase inhibitors enhance a Ca(2+)-activated K+ current (IAHP) and reduce IAHP suppression by a metabotropic glutamate receptor agonist in rat dentate granule neurones.
pubmed:affiliation
MRC Nerve Cell and Synapse Group, Faculty of Pharmacy, Toronto Hospital Research Institute, Ontario, Canada.
pubmed:publicationType
Journal Article, In Vitro, Research Support, Non-U.S. Gov't